Search For "clinical trial"
Russian envoy says cooperation in countering COVID-19 priority area of bil
Updated : 5 years, 3 months ago IST
New Delhi [India], December 2 (ANI): After phase 2/3 clinical trials for Sputnik V commenced in India on Tuesday, Russian Ambassador Nikolay Kudashev said comprehensive cooperation in countering the spread of coronavirus is a priority area of the Russia-India bilateral and multilateral strat
Read More
Clinical trials of Sputnik V vaccine begins in India
Updated : 5 years, 3 months ago IST
New Delhi [India], December 1 (ANI): Phase 2/3 clinical trials for Sputnik V, the first registered Covid-19 vaccine from Russia commenced in India on Tuesday.
Read More
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19, effi
Updated : 5 years, 3 months ago IST
New Delhi [India], November 23 (ANI): With an efficacy of around 90 per cent positive results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil the vaccine has proved to be highly effective in preventing COVID-19, said AstraZeneca on Monday.
Read More
UK's Oxford vaccine phase-2 trial indicates strong results in older adults
Updated : 5 years, 3 months ago IST
New Delhi [India], November 19 (ANI): In a major development, UK's Covid-19 vaccine has shown similar strong immune response in healthy older adults -aged 56 years and above- to those seen in people between 18 to 55 years, according to findings from a phase-2 trial.
Read More
Spain authorizes Phase 3 clinical trials of Janssen's COVID-19 vaccine
Updated : 5 years, 3 months ago IST
Madrid [Spain], November 18 (ANI/Sputnik): The Spanish Agency of Medicines and Medical Devices (AEMPS) authorized phase 3 clinical trials of the COVID-19 vaccine developed by Janssen, a subsidiary of the Johnson & Johnson company, the Spanish Health Ministry said on Wednesday.
Read More
Anil Vij offers to be 'first volunteer' for Phase-III trial of Covaxin in
Updated : 5 years, 3 months ago IST
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
Read More
Encouraged to hear Moderna's efficacy results of COVID-19 vaccine: WHO
Updated : 5 years, 3 months ago IST
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.
Read More
Moderna's Covid-19 vaccine is 94.5 pc effective
Updated : 5 years, 3 months ago IST
Massachusetts [US], November 16 (ANI): US biotech company Moderna on Monday announced a new potential Covid-19 vaccine, which has been shown to be 94.5 per cent effective at protecting people from coronavirus, according to interim results from late-stage clinical trials.
Read More
COVISHIELD completes enrolment of Phase III clinical trials under ICMR, SI
Updated : 5 years, 4 months ago IST
New Delhi [India], November 12 (ANI): The Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) have announced the completion of enrolment of phase 3 clinical trials for COVISHIELD in India.
Read More
Moderna expecting to announce results of COVID-19 vaccine by end of month
Updated : 5 years, 4 months ago IST
Washington [US], November 12 (ANI): Moderna expects to have an announcement on the efficacy of its COVID-19 vaccine after it finished accumulating data for a first analysis of the vaccine, the company said in a statement on Wednesday.
Read More
Brazil allows resumption of Chinese coronavirus vaccine trial
Updated : 5 years, 4 months ago IST
Ankara [Turkey], November 12 (ANI): Brazil's health regulator Anvisa on Wednesday (local time) announced the resumption of clinical trials of China's Sinovac COVID-19 vaccine.
Read More
New analysis finds lung cancer screening reduces rates of lung cancer-spec
Updated : 5 years, 4 months ago IST
Washington [US], November 11 (ANI): Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomised controlled clinical trials of lung cancer screening.
Read More